Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Albrecht Neesse

Showing results (71-80 of 111) with videos related to

Pageof 12
Sort By:
Cells|June 12, 2019
Preclinical Evaluation of 1,2-Diamino-4,5-Dibromobenzene in Genetically Engineered Mouse Models of Pancreatic CancerRobert G Goetze, Soeren M Buchholz, Ning Ou, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 10, 2013
CTGF antagonism with mAb FG-3019 enhances chemotherapy response without increasing drug delivery in murine ductal pancreas cancerAlbrecht Neesse, Kristopher K Frese, Tashinga E Bapiro, et al.
Endocrine-Related Cancer|September 25, 2014
CUX1: a modulator of tumour aggressiveness in pancreatic neuroendocrine neoplasmsSebastian Krug, Benjamin Kühnemuth, Heidi Griesmann, et al.
Digestion|April 28, 2026
Comparative assessment of diagnostic accuracy and puncture duration of two EUS-FNB needles (22G Franseen vs. 20G antegrade core trap) in patients with solid pancreatic lesionsGolo Petzold, Linda S Huhnold, Richard F Knoop, et al.
Cancers|July 24, 2020
Depletion of Macrophages Improves Therapeutic Response to Gemcitabine in Murine Pancreas CancerSoeren M Buchholz, Robert G Goetze, Shiv K Singh, et al.
World Journal of Gastroenterology|September 25, 2023
Machine learning-based decision tool for selecting patients with idiopathic acute pancreatitis for endosonography to exclude a biliary aetiologySimon Sirtl, Michal Żorniak, Eric Hohmann, et al.
Cancers|July 27, 2022
<i>TP53</i>-Status-Dependent Oncogenic EZH2 Activity in Pancreatic CancerLennart Versemann, Shilpa Patil, Benjamin Steuber, et al.
Gut|October 23, 2010
Stromal biology and therapy in pancreatic cancerAlbrecht Neesse, Patrick Michl, Kristopher K Frese, et al.
Theranostics|April 12, 2014
Real-time assessment of tissue hypoxia in vivo with combined photoacoustics and high-frequency ultrasoundMarco Gerling, Ying Zhao, Salvatore Nania, et al.
Cancers|March 11, 2023
Urokinase-Type Plasminogen Activator Receptor (uPAR) Cooperates with Mutated <i>KRAS</i> in Regulating Cellular Plasticity and Gemcitabine Response in Pancreatic AdenocarcinomasLuogen Peng, Yuchan Li, Sha Yao, et al.
Pageof 12

Showing results (71-80 of 111) with videos related to

Sort By:
Pageof 12
Cells|June 12, 2019
Preclinical Evaluation of 1,2-Diamino-4,5-Dibromobenzene in Genetically Engineered Mouse Models of Pancreatic CancerRobert G Goetze, Soeren M Buchholz, Ning Ou, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 10, 2013
CTGF antagonism with mAb FG-3019 enhances chemotherapy response without increasing drug delivery in murine ductal pancreas cancerAlbrecht Neesse, Kristopher K Frese, Tashinga E Bapiro, et al.
Endocrine-Related Cancer|September 25, 2014
CUX1: a modulator of tumour aggressiveness in pancreatic neuroendocrine neoplasmsSebastian Krug, Benjamin Kühnemuth, Heidi Griesmann, et al.
Digestion|April 28, 2026
Comparative assessment of diagnostic accuracy and puncture duration of two EUS-FNB needles (22G Franseen vs. 20G antegrade core trap) in patients with solid pancreatic lesionsGolo Petzold, Linda S Huhnold, Richard F Knoop, et al.
Cancers|July 24, 2020
Depletion of Macrophages Improves Therapeutic Response to Gemcitabine in Murine Pancreas CancerSoeren M Buchholz, Robert G Goetze, Shiv K Singh, et al.
World Journal of Gastroenterology|September 25, 2023
Machine learning-based decision tool for selecting patients with idiopathic acute pancreatitis for endosonography to exclude a biliary aetiologySimon Sirtl, Michal Żorniak, Eric Hohmann, et al.
Cancers|July 27, 2022
<i>TP53</i>-Status-Dependent Oncogenic EZH2 Activity in Pancreatic CancerLennart Versemann, Shilpa Patil, Benjamin Steuber, et al.
Gut|October 23, 2010
Stromal biology and therapy in pancreatic cancerAlbrecht Neesse, Patrick Michl, Kristopher K Frese, et al.
Theranostics|April 12, 2014
Real-time assessment of tissue hypoxia in vivo with combined photoacoustics and high-frequency ultrasoundMarco Gerling, Ying Zhao, Salvatore Nania, et al.
Cancers|March 11, 2023
Urokinase-Type Plasminogen Activator Receptor (uPAR) Cooperates with Mutated <i>KRAS</i> in Regulating Cellular Plasticity and Gemcitabine Response in Pancreatic AdenocarcinomasLuogen Peng, Yuchan Li, Sha Yao, et al.
Pageof 12